EyePoint Inc. (EYPT)
EYPT trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.07
-7.53% on the day
Market cap
$264.7M
Micro cap
Revenue · 2025
$31.4M
-27.5% on 2024
Net income · 2025
-$232.0M
-739.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | EYPT on Nasdaq |
| Sector | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001314102 |
| SEC industry code | Laboratory Analytical Instruments |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $31.4M |
| Net income | -$232.0M |
| Operating income | -$243.4M |
| Net margin | -739.4% |
| Operating margin | -776.0% |
| Revenue growth | -27.5% |
| Cash | $101.8M |
| Total assets | $364.0M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 8.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-11-06 |
| Latest annual report | 10-K | 2026-03-05 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-09-10 |
| Latest proxy | DEFA14A | 2026-04-27 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Peers in Biotechnology: Laboratory Analytical Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NAUT | Nautilus Biotechnology Inc. | $2.05 | -5.53% | $260.9M |
| LAB | Standard BioTools Inc. | $0.6589 | +0.17% | $260.0M |
| QTRX | Quanterix Corporation | $3.15 | -0.32% | $149.0M |
| SEER | Seer Inc. | $2.11 | -1.86% | $116.8M |
| PACB | Pacific Biosciences of California Inc. | $2.05 | -2.38% | $637.2M |
| CTKB | Cytek Biosciences Inc. | $5.35 | +0.75% | $695.4M |
| RPID | Rapid Micro Biosystems Inc. | $0.8738 | -0.57% | $43.8M |
| ALMR | Alamar Biosciences Inc. | $23.52 | -2.97% | $1.6B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier